A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population
Jan Lubiński(Tumour Institute of Tuscany), Sylvie Mazoyer(Université Claude Bernard Lyon 1), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust), Daniel Barrowdale(University of Cambridge), Jonathan J. Morrison(Uniformed Services University of the Health Sciences), Peter Devilee(Leiden University), Maaike P.G. Vreeswijk(Leiden University Medical Center), Christiana Kartsonaki(University of Oxford), Timothy G. Lesnick(Mayo Clinic in Florida), Agnes Jager(Erasmus MC Cancer Institute), Olivier Caron(Université Paris-Saclay), Hanne Meijers‐Heijboer(German Cancer Research Center), Carol Chu(Lyon 1 Université), Rob B. van der Luijt(Institute for Quality and Efficiency in Health Care), D. Gareth Evans(Manchester Academic Health Science Centre), Robert F. Tarrell(University of Cambridge), Maya Ghoussaini(National Health Service), Susan Peock(Guy's and St Thomas' NHS Foundation Trust), Zachary S. Fredericksen(Leiden University), Debra Frost(University of Cambridge), Sophie Giraud(The Netherlands Cancer Institute), Frans B.L. Hogervorst(The Netherlands Cancer Institute), Matti A. Rookus(Leiden University Medical Center), Pascaline Berthet(Centre François Baclesse), Christine Lasset(Lyon 1 Université), Ans van den Ouweland(Erasmus MC), Fiona Douglas(University of Southern California), Lesley McGuffog(University of Cambridge), J. Paterson(Institut Gustave Roussy), Claude Houdayer(Inserm), Sue Healey(QIMR Berghofer Medical Research Institute), Dominique Stoppa-Lyonnet(Inserm), Clare Oliver(University of Cambridge), Xianshu Wang(Mayo Clinic), Margaret Cook(University of Cambridge), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Antonis C. Antoniou(Mayo Clinic), Olga M. Sinilnikova(Hospices Civils de Lyon), Agnès Hardouin(University Medical Center Utrecht), E. Gómez(Maastricht University Medical Centre), Diana Eccles(Princess Anne Hospital)
Cited by 344
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
The evolutionary history of lethal metastatic prostate cancer
|Nature|2015|1.4k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k